Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Camargo-Coronel, A. Quiñones-Moya, H. Hernández-Zavala, M. R. Hernández-Vázquez, J. R. Vázquez-Zaragoza, MÁ

Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Shi, H. Sun, J. Zeng, Y. Wang, X. Liu, S. Zhang, L. Shao, E.

Immune escape of SARS-CoV-2 variants to therapeutic monoclonal antibodies: a system review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ho, T. C. Shen, D. H. Chang, C. C. Chan, H. P. Chuang, K. P. Yuan, C. H. Chen, C. N. Yang, M. H. Tyan, Y. C.

Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Elsaid, M. Nune, A. Brakat, A. M. Anand, A. Alashwah, M. Maher, A. Lama, N. Penamante, C. A. C.

Immune thrombocytopenic purpura after influenza vaccine administration; a systematic review and meta-analysis

  • Children
  • Adults
  • Older adults
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Cheng, M. Q. Li, R. Weng, Z. Y. Song, G.

Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Karofi, D. H. Lawal, N. Bello, M. B. Imam, M. U.

Immunogenicity and Protective Efficacy of Nucleic Acid-Based Vaccines Against COVID-19: A Systematic Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Katoto, P. D. Kakubu, M. A. Tamuzi, J. L. Brand, A. S. Ayuk, A. Byamungu, L. N. Wiysonge, C. S. Gray, G.

Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses

  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Li, P. Wang, W. Tao, Y. Tan, X. Li, Y. Mao, Y. Gao, L. Feng, L. Zhan, S. Sun, F.

Immunogenicity and reactogenicity of heterologous immunization schedules with COVID-19 vaccines: a systematic review and network meta-analysis

  • Adults
  • COVID-19
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Cheng, M. Q. Li, R. Luo, X. Chen, J. Y. Bai, Z. P. Zhao, P. Weng, Z. Y. Song, G.

Immunogenicity and safety of adjuvant-associated COVID-19 vaccines: A systematic review and meta-analysis of randomized controlled trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Zhao, T. Yang, Z. Wu, Y. Yang, J.

Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
Loading...